SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : IMGN
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Alicia V. Johnson who wrote (4)8/6/1996 9:07:00 PM
From: Brian J Russell   of 24
 
This is what the Wall St. Journal said in its "Small Stocks Section"
of the Interative edition.

ImmunoGen gained 2 1/16, or 64% to 5 5/16 after it said
an experimental compound, administered in doses well
below those that produce toxic side effects, eradicated
human colon tumors grown in mice. The company said the
studies suggest a new approach to the treatment of
colorectal cancer.

Basically the standard mention for a big gainer, but the coverage is
good nonetheless.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News